Patent application number | Description | Published |
20140058070 | C-TERMINAL AMIDATION OF POLYPEPTIDES - There are provided compounds and methods for amidating the C-terminus of a polypeptide. The method include reacting a polypeptide which includes a C-terminal thioester or C-terminal selenoester with any one of a defined set of auxiliary molecules under conditions suitable to produce a polypeptide adduct which includes the auxiliary molecule chemically bound at the C-terminal of the polypeptide. In the subsequent step, the auxiliary molecule is removed from the C-terminal of the polypeptide adduct under conditions suitable to produce an amidated polypeptide. | 02-27-2014 |
20140221282 | LONG DURATION DUAL HORMONE CONJUGATES - There are provided compounds having two peptide hormones bound to a central water-soluble polymeric spacer and methods of use thereof. | 08-07-2014 |
20140221287 | Amylin Peptides and Derivatives and Uses Thereof - There are provided polypeptide conjugates having enhanced duration of biological activity, and methods of use thereof. The polypeptide conjugates include duration enhancing moieties, including water soluble polymers, bound to the polypeptide components of defined sequence. Methods of use are provided for treatment of metabolic disorders. Methods of use are provided for treatment of an eating disorder, insulin resistance, obesity, overweight, abnormal postprandial hyperglycemia, Type I diabetes, Type II diabetes, gestational diabetes, metabolic syndrome, dumping syndrome, hypertension, dyslipidemia, cardiovascular disease, hyper lipidemia, sleep apnea, cancer, pulmonary hypertension, cholescystitis, osteoarthritis, or short bowel syndrome. | 08-07-2014 |
Patent application number | Description | Published |
20130129725 | HUMAN FGF RECEPTOR AND BETA-KLOTHO BINDING PROTEINS - The present invention provides compositions and methods relating to or derived from antigen binding proteins and antigen binding protein-FGF21 fusions that specifically bind to β-Klotho, or β-Klotho and one or more of FGFR1c, FGFR2c, FGFR3c, and FGFR4. In some embodiments the antigen binding proteins and antigen binding protein-FGF21 fusions induce FGF21-like signaling. In some embodiments, an antigen binding protein or antigen binding protein-FGF21 fusion antigen binding component is a fully human, humanized, or chimeric antibody, binding fragments and derivatives of such antibodies, and polypeptides that specifically bind to β-Klotho, or β-Klotho and one or more of FGFR1c, FGFR2c, FGFR3c, and FGFR4. Other embodiments provide nucleic acids encoding such antigen binding proteins and antigen binding protein-FGF21 fusions, and fragments and derivatives thereof, and polypeptides, cells comprising such polynucleotides, methods of making such antigen binding proteins and antigen binding protein-FGF21 fusions, and fragments and derivatives thereof, and polypeptides, and methods of using such antigen binding proteins and antigen binding protein-FGF21 fusions, fragments and derivatives thereof, and polypeptides, including methods of treating or diagnosing subjects suffering from type 2 diabetes, obesity, NASH, metabolic syndrome and related disorders or conditions. | 05-23-2013 |
20140243503 | FGF21 MUTANTS AND USES THEREOF - The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. | 08-28-2014 |
20140274874 | VARIANTS OF TISSUE INHIBITOR OF METALLOPROTEINASE TYPE THREE (TIMP-3), COMPOSITIONS AND METHODS - There are disclosed TIMP-3 muteins, variants and derivatives, nucleic acids encoding them, and methods of making and using them. | 09-18-2014 |
20140323396 | FGF21 MUTANTS AND USES THEREOF - The invention provides nucleic acid molecules encoding FGF21 mutant polypeptides, FGF21 mutant polypeptides, pharmaceutical compositions comprising FGF21 mutant polypeptides, and methods for treating metabolic disorders using such nucleic acids, polypeptides, or pharmaceutical compositions. | 10-30-2014 |
20140356358 | VARIANT FC-POLYPEPTIDES WITH ENHANCED BINDING TO THE NEONATAL FC RECEPTOR - Described herein are variant Fc-fragments that contain an insertion within or adjacent to a loop that bind to the neonatal Fc receptor (FcRn) with higher affinity and/or higher binding activity at pH 5-6 and approximately the same or lower affinity at a physiologic pH as compared to a control Fc-fragment, that is, little or no binding activity at a physiologic pH. Also described are variant Fc-polypeptides that comprise these variant Fc-fragments. Further described are methods of making and identifying such Fc-fragments and methods for making and using such Fc-polypeptides. | 12-04-2014 |
Patent application number | Description | Published |
20120076157 | ENHANCED ACCESS CHANNEL MASKS FOR xHRPD - Disclosed is a method of performing Pseudo-random-Noise (PN) quadrature covering for transmitting data via an access channel. Such method is achieved by receiving a 42-bit access long code mask MI | 03-29-2012 |
20120082095 | ATTENTION COMMANDS ENHANCEMENT - An apparatus includes a Mobile Termination (MT) that offers functions related to communication with a network, a Terminal Equipment (TE) that offers services to a user of the apparatus, and a Terminal Adaptor (TA) that allows communication between the MT and the TE using Attention (AT) commands. A packet domain event reporting command (+CGEREP) is one type of AT command that enables or disables sending of result codes from the MT to the TE in case certain events occur in the MT for a packet domain or in the network. One such type of event is a Packet Data Protocol (PDP) context activation, for which the MT sends to the TE a result code that includes an integer type parameter to indicate the reason why a context activation request with PDP type IPv4v6 was not granted, and a context id parameter to indicate the capability of Mobile Termination for autonomously requesting a second address bearer, and the result of the second address bearer activation. | 04-05-2012 |
20140071927 | ENHANCED ACCESS CHANNEL MASKS FOR xHRPD - Disclosed is a method of performing Pseudo-random-Noise (PN) quadrature covering for transmitting data via an access channel. Such method is achieved by receiving a 42-bit access long code mask MI | 03-13-2014 |
20150256381 | ATTENTION COMMANDS ENHANCEMENT - A method of packet domain event reporting performed by a user equipment (UE) including a mobile termination (MT) and a terminal equipment (TE), and the user equipment thereof. The method according to one embodiment includes performing, by the MT, context activation for establishing a dual-stack bearer between the MT and a network; receiving, by the MT from the network, information indicating that the context activation of the dual-stack bearer is not possible between the network and the MT; and sending, by the MT to the TE, a message including a reason parameter for indicating a reason as to why the context activation of the dual-stack bearer is not possible between the network and the MT, when a requested Packet Data Protocol (PDP) type is Internet Protocol (IP) v4v6 and a assigned PDP type is either IPv4 or IPv6. | 09-10-2015 |
Patent application number | Description | Published |
20080268066 | Synergistic Formulation for Preventing and/or Treating Diabetes - The present invention discloses a composition preparation for preventing and treating diabetes, which mainly contains oral hypoglycemic agents, Vitamin E, chromic pyridine formate, selenium, lutein, folic acid, Vitamin C, alpha_lipoic acid, lycopene, nicotinamide, coenzyme Q10, and vitamin complexes and mineral. The medicament of the invention can decrease oxidative stress in vivo, promote body immunity, repair the critical organs in vivo such as pancreas, by supplying the mineral, vitamins and other substances which are insufficient in the patient suffering from diabetes, to prevent and treat diabetes. | 10-30-2008 |
20090043115 | Process for Producing Simvastatin - The present invention discloses a process for producing Simvastatin and intermediate thereof. The present invention uses inexpensive and easily available reagents, its condition is mild, and it leaves out the protective and deprotective steps, which are necessary in prior methods. Compared with prior art, the esterifying condition in 8-position is greatly simplified. | 02-12-2009 |
20090196910 | Sustained-Release Preparation of Statin Drugs - A preparation of statins for prolonged release. The preparation is a transdermal therapeutic system or hypodermic implantation system. And they overcome the problem of low bioavailability and increase patient compliance. The statins in the invention contain all of statins and responding salts, hydroxyl ester derivatives at 4-position. The invention has many advantages: for example, reduce dosage frequency, remain stable and lasting blood concentration of medicine, further improve the curative effect, provide patients with a convenient and safety means of administration, and obtain an effective period of up to seven days to months by taking medicine once. | 08-06-2009 |
20090326286 | PROCESS OF PRODUCING LIQUID FUEL FROM CELLULOSIC BIOMASS - A liquid fuel production process from cellulosic biomass comprises the following steps: (1) providing a mixture of cellulose and water; (2) subjecting the obtained mixture to hydrolysis and catalytic hydrogenation under the presence of acid to obtain mono-sugar alcohol and optional solid material lignin, or subjecting the obtained mixture to hydrolysis to obtain monosaccharide; (3) esterifying the obtained mono-sugar with C | 12-31-2009 |
20100015115 | COMPOUND PREPARATION FOR QUICKLY REDUCING OXIDATIVE STRESS AND PREPARATION OF THE SAME - The present invention discloses a compound preparation for quickly reducing oxidative stress, which contains small molecules and mineral trace elements that can remove or help removing free radicals, can regulate the function of endocrine and circulatory digestive system, as well as other components that can rebuild inner harmony. The compound preparation is in solid dosage form, preferably effervescent tablet or effervescent granules. The preparative method of the compound preparation is also disclosed. Animal experiment and clinical trial show that the invention has strong effect in reducing oxidative stress and disease prevention. | 01-21-2010 |
20100105691 | METFORMIN FOLATE AND PREPARATION OF THE SAME - The present invention discloses a novel biguanidine compound, i.e. folacin-metformin, and its manufacture with inorganic salt of metformin as raw material. Compared with metformin, the compound has the same clinic curative effect, such as lowering blood sugar, curing poly-cystic ovary syndrome (PCOS), losing weight and so on, without resulting in the increase of homocysteine concentration, even with a little decrease of homocysteine concentration in some cases. | 04-29-2010 |
20100186291 | LIQUID FUEL PRODUCTION PROCESS FROM CELLULOSIC BIOMASS AND COAL - A liquid fuel production process from Cellulosic biomass and coal comprises providing a mixture of Cellulosic biomass and coal, subjecting the mixture to gasification to obtain synthesis gas and converting the synthesis gas to a liquid fuel under the presence of catalyst. The catalyst includes molybdenum sulfide, alkali metal compound and a component activating the C—H bond in alkanes product, wherein the alkali metal compound is selected from the group of salts of Li, Na, K, Rb and Cs, the component activating the C—H bond in alkanes product is selected from Mo, V, Os, Re, Ir, Pt, Pd, Co, Rh, Ni and their mixture. Additionally, co-gasification of Cellulosic biomass and coal can reduce the ash fusion temperature of coal. | 07-29-2010 |
20110180752 | Process for Direct Liquification of Cellulosic Biomass - The invention provides a process for direct liquification of cellulosic biomass, which may be used to liquefy all of the organics in cellulosic biomass, including all high molecular polymeric components such as carbohydrates and lignins, into small molecular organics in a short time under mild conditions. In other words, there is provided a technology capable of converting cellulosic biomass into oil. The resultant renewable high-quality oil may be converted into liquid fuels such as gasoline etc., or used as starting materials in chemical engineering industry. The technology for direct liquification of cellulosic biomass as disclosed in the invention is the first one-step process in the world for direct liquification of cellulosic biomass without black tar formation and gasification. | 07-28-2011 |
20110223643 | SYSTEM FOR BIONIC CATALYTIC HYDROLYZING CELLULOSE AND ITS USE IN PRODUCING LIQUID FUEL FROM CELLULOSE BIOMASS - A bionic catalyst for hydrolyzing cellulose and hemicellulose and its preparation method. The catalyst comprises double acid radical catalytic portions and cellulose-linking portions, and can be used under room temperature and high temperature. The catalyst can hydrolyze cellulose and hemicellulose simultaneously, while not decompose glucose and xylose, and may be recycled efficiently. The catalyst can be combined with the process in the prior art to produce liquid fuel. | 09-15-2011 |
20120245367 | Process for Producing Ester of Carboxylic Acid from Cellulosic Biomass - The invention discloses a technology for producing ester of carboxylic acid using cellulosic biomass as starting material. This technology comprises the following key steps: converting all of the organic polymers, including such high molecular-weight polymers as carbohydrate components and lignin, in cellulosic biomass into water soluble, small molecular organics completely in relatively short time under relatively mild conditions; separating the resultant water soluble compounds containing aromatic rings by adjusting the acidity/basicity of the reaction solution or by using adsorption resin; and converting the water soluble compounds containing aromatic rings into ester of carboxylic acid by hydrogenation and esterification in a corresponding alcohol solution. | 09-27-2012 |
20130092602 | Continuous Reaction System Comprising Subcritical Or Supercritical Liquid As Solvent And Reactant As Solid - A continuous reaction system is provided, which specifically relates to a continuous reaction system comprising subcritical and/or supercritical liquid as solvents and a reactant as solid. The invention can effectively prevent cavitations in the reaction system effectively, and realize maximum conversion of the solid reactant material. | 04-18-2013 |
20130123547 | Simultaneous Hydrolysis Refine Method Of Cellulose Biomass - A method of refining cellulosic biomass, including synchronous hydrolyzation of at least 85 wt % organic polymers, based on the total weight of the cellulosic biomass, in the cellulosic biomass into small molecular organic compounds. The synchronous hydrolyzation is catalytic hydrolyzation for which the catalyst used is a substance represented by L-M-S-H or L-M=S, wherein “M” represents metal, carbon or silicon, “S” represents a heteroatom, “L” represents one or more ligands, and “H” represents hydrogen. | 05-16-2013 |
Patent application number | Description | Published |
20080212598 | System and Method for Transparent Virtual Routing - A transparent routing device disposed within an access network configured in accordance with one or more lower-layer protocols is disclosed herein. The device includes a set of subscriber-side ports. Each of the subscriber-side ports is associated with a plurality of virtual subscriber-side interfaces disposed to effectively terminate a corresponding plurality of subscriber-side connections with subscriber host devices served by the access network. The device further includes at least one network-side port through which communication occurs with an external network in accordance with a higher-layer protocol. A routing table is configured to establish a correspondence between network addresses of the subscriber host devices and the plurality of virtual subscriber-side interfaces. During operation of the device, packets received through the at least one network-side port are forwarded to corresponding ones of the virtual subscriber-side interfaces based upon network addresses of the packets. | 09-04-2008 |
20090138609 | Method and Apparatus for Maintaining User Sessions Across User Devices and Portals - Embodiments of the invention generally provide a method and apparatus for maintaining user sessions across user devices and portals. One embodiment of a method for maintaining a user session across a group including a plurality of user devices includes altering, at a first device in the group, a state of the user session, such that a new session state results and transferring the new session state from the first device to at least one of the other devices in the group. | 05-28-2009 |
20120042091 | METHOD AND APPARATUS RELATED TO VARILABLE DURATION MEDIA SEGMENTS - A method and apparatus for an adaptive bit rate system ( | 02-16-2012 |
20120137015 | METHOD OF TARGETED AD INSERTION USING HTTP LIVE STREAMING PROTOCOL - A content delivery system and method that receives a request for a content stream that includes splice points. The method receives a playlist that includes an ordered list of media segment files that represent the content stream, and splice point tags, where generation of the media segment files aligns segment boundaries with the splice points in the content stream, and where each splice point tag is in a location in the playlist that corresponds to the position of one of the splice points in the content stream. The method identifies an insertion position in the playlist based on the location of the splice point tags, selects an advertisement segment, inserts the advertisement segment at the insertion position to create a modified playlist, removes the splice point tags from the modified playlist, and sends the modified playlist to the video display device. | 05-31-2012 |
20130064283 | ENCODER-AIDED SEGMENTATION FOR ADAPTIVE STREAMING - In one embodiment, a method for encoding content includes receiving source content and encoding the source content into a plurality of content streams. The encoding includes aligning the plurality of content streams at Group of Pictures (GOP) boundaries. The encoding further includes embedding, in each content stream, metadata identifying segmentation points within the content stream, where the segmentation points correspond to one or more of the GOP boundaries. | 03-14-2013 |
20130219423 | Algorithmic Media Stream Selection - In embodiments of algorithmic media stream selection, a media routing device ( | 08-22-2013 |
20140050082 | DEVICES, SYSTEMS, AND METHODS FOR ADAPTIVE SWITCHING OF MULTICAST CONTENT DELIVERY TO OPTIMIZE BANDWIDTH USAGE - Systems, devices and methods for adaptive switching in multicast media streams are disclosed herein. In an embodiment, a method for adaptively transmitting content to one or more users based on currently available bandwidth via internet protocol (“IP”) multicast protocol, includes: receiving a first content stream having a plurality of data packets, the first content stream encoded at a first bit rate; receiving a second content stream having a plurality of data packets, the second content stream encoded at a second bit rate, wherein the first bit rate is different than the second bit rate and wherein the first and second content streams represent the same content; transmitting the first content stream to a user; determining that the user could receive the second content stream based on available bandwidth for transmitting data to the user; and transmitting the second content stream to the user. | 02-20-2014 |
20140281002 | DEVICES, SYSTEMS, AND METHODS FOR MANAGING AND ADJUSTING ADAPTIVE STREAMING TRAFFIC - Systems, devices and methods for managing and adjusting adaptive streaming traffic to optimize fairness are disclosed herein. In one embodiment, a method comprises: receiving a request for a media segment; locating the media segment; determining the bitrate of the requested media segment; and assigning priority information to the media segment, wherein a media segment having a lowest guaranteed bitrate is assigned a higher priority than media segments having higher bitrates. | 09-18-2014 |
20140282787 | SYSTEM AND METHOD FOR MULTISCREEN NETWORK DIGITAL VIDEO RECORDING USING ON-DEMAND TRANSCODING - A method is disclosed that includes: receiving, via a network digital video recorder, a request to record requested content; receiving, via a network digital video recorder at a first time, the requested content in a first format and the requested content in a second format; storing, via the network digital video recorder, the requested content in the first format; storing, via the network digital video recorder, the requested content in the second format; deleting, from network digital video recorder, the requested content in the second format after a predetermined time period; and transcoding, via an on demand transcoder, the requested content in the first format to the requested content in a third format after the predetermined time period. | 09-18-2014 |
Patent application number | Description | Published |
20100260757 | USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY - This invention relates to methods of modifying pyridoxal 5′ phosphate (PLP) dependent enzymes to extend the serum half-life of the enzyme, extend the in vivo period of methionine depletion in a host, and decrease the immunogenicity of the enzyme. A preferred PLP-dependent enzyme to be modified is a methioninase, preferably a recombinant methioninase (rMETase). The invention further relates to compositions comprising a modified PLP-dependent enzyme and methods of using the same. | 10-14-2010 |
20100331529 | METHODS FOR INCREASING PROTEIN POLYETHYLENE GLYCOL (PEG) CONJUGATION - The present invention relates to highly conjugated proteins and methods for making such proteins. In particular, the present invention relates to methods for linking additional sites to a protein for conjugation with activated polyethylene glycol (PEG) linkers, without denaturing the protein. The invention also relates to highly conjugated proteins with decreased immunogenicity and increased circulating half-life. | 12-30-2010 |
20130252306 | METHODS FOR INCREASING PROTEIN POLYETHYLENE GLYCOL (PEG) CONJUGATION - The present invention relates to highly conjugated proteins and methods for making such proteins. In particular, the present invention relates to methods for linking additional sites to a protein for conjugation with activated polyethylene glycol (PEG) linkers, without denaturing the protein. The invention also relates to highly conjugated proteins with decreased immunogenicity and increased circulating half-life. | 09-26-2013 |
20140205583 | USE OF PLP WITH PEG-rMETase IN VIVO FOR ENHANCED EFFICACY - This invention relates to methods of modifying pyridoxal 5′ phosphate (PLP) dependent enzymes to extend the serum half-life of the enzyme, extend the in vivo period of methionine depletion in a host, and decrease the immunogenicity of the enzyme. A preferred PLP-dependent enzyme to be modified is a methioninase, preferably a recombinant methioninase (rMETase). The invention further relates to compositions comprising a modified PLP-dependent enzyme and methods of using the same. | 07-24-2014 |
Patent application number | Description | Published |
20130121427 | SCALED POWER LINE BASED NETWORK - A power line communication network includes a first power line communication sub-network, a second power line communication sub-network, and an isolation filter disposed between first and second power line communication sub-networks. The isolation filter is configured to pass electrical power signals between the first and second power line communication sub-networks, and to block passage of data communication signals from the first power line communication sub-network to the second power line communication sub-network. | 05-16-2013 |
20130179715 | SYSTEMS AND METHODS FOR REDUCING ENERGY CONSUMPTION IN SENSOR NETWORKS - A system includes a volatile memory and state information management logic. The volatile memory includes a plurality of volatile storage locations. The state information management logic includes memory write tracking circuitry coupled to the volatile memory. The memory write tracking circuitry is configured to identify locations of the memory written subsequent to restoration of state information to the volatile memory on exit of a low-power mode of operation, and to store indicia of the identified locations. | 07-11-2013 |
20130217399 | PARTIAL CHANNEL MAPPING FOR FAST CONNECTION SETUP IN LOW ENERGY WIRELESS NETWORKS - A system comprising a controller, a scanner, and a transceiver. The controller is configured to identify a number of channels in which a beacon signal may be wirelessly transmitted. The number of channels is less than a total number of channels available for receiving transmissions. The scanner is configured to scan each of the number of channels for a first beacon signal. The transceiver is configured to receive the first beacon signal from one of the number of channels. | 08-22-2013 |
20130259016 | COEXISTENCE OF WIRELESS SENSOR NETWORKS WITH OTHER WIRELESS NETWORKS - A wireless device includes a wireless transceiver configured to transmit to and receive from nodes in a wireless sensor network (WSN) and control logic coupled to the first wireless transceiver. The wireless transceiver transmits a wireless packet to a node in the WSN based on the transmission coinciding with a break in transmissions for a second wireless network. Based on the wireless transceiver being configured to transmit the wireless packets utilizing time synchronized channel hopping, slot frames for packet transmissions in the WSN are time offset so as not to coincide with transmissions made on the second wireless network. Based on the wireless transceiver being configured to transmit the packets utilizing coordinated sampled listening, wake up sequence transmissions for the WSN are time offset so as not to coincide with the transmissions made on the second wireless network. | 10-03-2013 |
20130301453 | WIRELESS NETWORK WITH POWER AWARE TRANSMISSION CONTROL - A wireless device that tailors communications based on power parameters of the device. In one embodiment, a wireless device includes an energy source, a power monitor coupled to the energy source, a wireless transceiver, and a traffic controller coupled to the power monitor and the wireless transceiver. The power monitor is configured to measure a parameter of the energy source. The wireless transceiver is configured to wirelessly communicate via a wireless network. The traffic controller is configured to set length of packets to be transmitted based on the measured parameter of the energy source. | 11-14-2013 |
20140146808 | POWER EFFICIENT TUNNELED DIRECT LINK SETUP APPARATUS, SYSTEMS AND METHODS - Apparatus, systems, and methods disclosed herein operate to provide wireless communication between personal mobile communication (PMC) devices. An emulated wireless access point (AP) at a first PMC device (PMC1) establishes a first tunneled direct link setup (TDLS) session between a first station module (STA1) incorporated into the PMC1 and a second station module (STA2) incorporated into a second PMC device (PMC2). Following establishment of the TDLS session, the wireless AP is allowed to sleep; and most infrastructure management duties are handled by the STA1 during the session. PMC device battery charge may be conserved as a result. The emulated wireless AP may also establish a second TDLS link to a third station module (STA3) incorporated into a third PMC device (PMC3). The STA1 may then bridge data traffic flow between the STA2 and the STA3. Such bridging operation may enable communication between two PMC devices otherwise unable to decode data received from the other. | 05-29-2014 |
20140293984 | ENHANCING PACKET AGGREGATION PERFORMANCE IN COEXISTING WIRELESS NETWORKS - A wireless combination (combo) device is coupled to an antenna for communicating via a first wireless network over a first band. A packet aggregator is coupled to the first wireless transceiver configures a frame aggregated packet for at least a portion of activities on the first wireless network. The frame aggregated packet includes a plurality of data packets and a dummy packet or spoofing so that said frame aggregated packet is extended in time or indicates an extension sufficient to overlap a Tx time interval or Rx time interval for communications occurring over a second wireless network. The first wireless network and said second wireless network are overlapping networks. | 10-02-2014 |
20140341100 | ACCESS POINT-AIDED COEXISTENCE/CONCURRENCY AT MOBILE DEVICES - Methods, systems, and devices are described that enable a WLAN access point (AP) to schedule packet transmissions to (or from) a mobile device taking into consideration the schedule of various other coexisting transmission/reception (Tx/Rx) activities on the mobile device. Various approaches may increase throughput at the mobile device. Various approaches also may benefit other stations associated with the same AP. | 11-20-2014 |
20150016393 | SYSTEMS AND METHODS FOR SILENCING WIRELESS DEVICES - Embodiments provide systems and methods to optimize the time when to receive transmissions from dissimilar wireless networks, and hence, improve the overall network throughput and avoid access point transmission rate fall-back mechanism having an avalanche effect during coexistence of dissimilar wireless network technologies. A receiver comprises at least two dissimilar network technology subsystems and is able to receive transmissions from dissimilar wireless network technology subsystems during a predetermined reception window. | 01-15-2015 |
20150030010 | SYNCHRONIZED CHANNEL ACCESS IN COEXISTING WIRELESS NETWORKS - A system and method for arbitrating channel access in a wireless device including co-located network transceivers are disclosed herein. A wireless device includes a first wireless transceiver and a second wireless transceiver. The first transceiver is configured for operation with a first wireless network. The second transceiver is configured for operation with a second wireless network. The wireless device further includes logic that determines which of the first and second transceivers is enabled to transmit at a given time. The logic causes the first transceiver to transmit a notification signal indicating a time period during which the second transceiver of the wireless device will perform a first wireless transaction, and during which, based on receiving the notification signal, a different wireless device performs a second wireless transaction via the second wireless network without transmitting a notification signal. | 01-29-2015 |
20150052231 | PROVIDING CUSTOM NAMES FOR HEADLESS DEVICES - A headless device does not have a user interface that conveniently allows the user to enter a custom name for the headless device. In this disclosure, a custom name may be determined (either automatically or via user input) at a user device, such as a user device that has a user interface. The custom name may be based on the type of device, location, services, and/or other information about the headless device. The custom name is introduced to the communications network in association with a network address of the headless device. In some embodiments, forged messages based on conventional network protocols may be used to associate the custom name with the network address of the headless device. | 02-19-2015 |
20150052255 | MINIMIZING COVERAGE HOLES IN A COMMUNICATION NETWORK - Access point functionality of a network device may be disabled, resulting in a coverage hole in a communication network and affecting performance of a client device. Various techniques can be implemented for detecting and minimizing coverage holes. In one embodiment, the network device can selectively establish a communication link with the client device depending on whether the client device is in a coverage hole and depending on whether the client device can detect another access point in the communication network. In some embodiments, the client device can determine that it is in a coverage hole in response to detecting a reserved SSID and can accordingly notify a central coordinator of the communication network. In some embodiments, the central coordinator can identify the network device (with disabled access point functionality) that can eliminate the coverage hole and can cause the network device to enable its access point functionality. | 02-19-2015 |
20150085844 | ACCESS POINT COORDINATED RE-ASSOCIATION OF WIRELESS DEVICES - A first AP in a wireless network determines that a wireless client device should re-associate from the first AP to a second AP of the wireless network. The first AP communicates an AP coordination message from the first AP to the second AP to share coordination information with the second AP. The first AP coordinates with the second AP to cause the re-association of the wireless client device in accordance with the coordination information. The first and second AP may coordinate directly to synchronize re-association activities. Re-association activities may include the use of a configuration message to the wireless client device, managing transmit power of beacon messages from the first and second APs, or forced disassociation and blocking. The first AP may maintain a record of which re-association activity was successful in causing the wireless client device to re-associate to the second AP. | 03-26-2015 |
20150222327 | SCALED POWER LINE BASED NETWORK - A power line communication network includes a plurality of PLC devices. The PLC devices communicate packets over conductors of an electrical power distribution system via a plurality of non-interfering channels. Different ones of the PLC devices are configured to communicate packets via different ones of the non-interfering channels. | 08-06-2015 |
20150222328 | SCALED POWER LINE BASED NETWORK - A power line communication system includes a first power line communication device. The first device is configured to communicate via conductors of an electrical power distribution system. The first device has a transmitter power control system which is configured to determine transmission power needed to communicate with a second device of a power line communication network. The first device also configured to apply the determined transmission power to communicate with the second device. The determined transmission power is insufficient to communicate with a third device of the power line communication network, and the transmitter power control system is configured to determine transmission power needed to communicate with a third device. | 08-06-2015 |
20150334728 | SYSTEMS AND METHODS FOR TIME OPTIMIZATION FOR SILENCING WIRELESS DEVICES IN COEXISTENCE NETWORKS - Embodiments provide a communication device. A device comprises at least two dissimilar network technology subsystems, at least one subsystem of which is lower priority than at least another of the dissimilar subsystems. In some embodiments, a device is able to transmit a silencing frame during a transmission window within a lower priority technology network interval. A transceiver is able to calculate a transmission window to end by at least a duration of time to complete transmission of the silencing frame prior to the beginning of next immediate string of at least one higher priority network technology subsystem interval, and transmit a silencing frame during a lower priority technology network interval during the transmission window. | 11-19-2015 |
Patent application number | Description | Published |
20090209481 | Nucleoside prodrugs and uses thereof - Compounds having the formula I or II wherein R | 08-20-2009 |
20120039845 | NUCLEOSIDE PRODRUGS AND USES THEREOF - Compounds having the formula I or II, wherein R | 02-16-2012 |
20120214769 | Novel Antagonists of the Glucagon Receptor - The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistance and hyperglycemia. The present invention also provides for processes of making the compounds of Formula I, including salts and co-crystals thereof, and pharmaceutical compositions comprising the same. | 08-23-2012 |
20130030029 | Glucagon Antagonists - Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provided herein are pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistance and hyperglycemia. Moreover, provided herein are methods of making or manufacturing compounds disclosed herein, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or Co-crystals and prodrugs thereof. Formula I | 01-31-2013 |
20140135400 | NOVEL ANTAGONISTS OF THE GLUCAGON RECEPTOR - The present invention provides for novel compounds of Formula (I) and pharmaceutically acceptable salts and co-crystals thereof which have glucagon receptor antagonist or inverse agonist activity. The present invention further provides for pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistance and hyperglycemia. The present invention also provides for processes of making the compounds of Formula I, including salts and co-crystals thereof, and pharmaceutical compositions comprising the same. | 05-15-2014 |
20150087680 | GLUCAGON ANTAGONISTS - Provided herein are compounds, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or co-crystals and prodrugs thereof which have glucagon receptor antagonist or inverse agonist activity. Further, provided herein are pharmaceutical compositions comprising the same as well as methods of treating, preventing, delaying the time to onset or reducing the risk for the development or progression of a disease or condition for which one or more glucagon receptor antagonist is indicated, including Type I and II diabetes, insulin resistance and hyperglycemia. Moreover, provided herein are methods of making or manufacturing compounds disclosed herein, including enantiomerically pure forms thereof, and pharmaceutically acceptable salts or Co-crystals and prodrugs thereof. Formula I | 03-26-2015 |